Álvaro Rodríguez-Lescure

15PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

|Feb 24, 2026
Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM).

Sara López-Tarruella, Ángel Guerrero-Zotano, Silvia Antolín

|Nov 25, 2025
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.

Álvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso

|Sep 19, 2025
Reply to: From Discussion to Direction: Tumor Boards Need Clinical Editorial Leadership.

Miguel Borregón Rivilla, María Torrente, Álvaro Rodríguez-Lescure

|Jul 30, 2025
Revisiting Alma Ata: A Blueprint for Cancer Care.

Javier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla

|Jun 05, 2025
Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management.

Miguel Borregón, María Torrente, Álvaro Rodríguez-Lescure

Pageof 3

Frequent Collaborators

5 joint publications

Javier-David Benitez-Fuentes

4 joint publications

Miguel Borregon Rivilla

2 joint publications

María Torrente

2 joint publications

Alicia de Luna Aguilar